5 disclosed rounds · sourced from the FOBI roster
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| 2025-10-17 | Acquired | $533M | — | Boston Scientific |
| 2024-01-03 | Series E | $85M | — | Novo Holdings |
| 2020-07-01 | Series C | $65M | — | Boston Scientific |
| 2018-01-01 | Series B | $35M | — | Boston Scientific |
| 2015-07-08 | Series A | $11.9M | — | — |